All Updates

All Updates

icon
Filter
Partnerships
Devyser Diagnostics partners with Hamilton Bonaduz to automate library preparation of NGS kits and market Hamilton’s liquid handling technologies
Precision Medicine
Apr 23, 2024
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Precision Medicine

Precision Medicine

Apr 23, 2024

Devyser Diagnostics partners with Hamilton Bonaduz to automate library preparation of NGS kits and market Hamilton’s liquid handling technologies

Partnerships

  • Devyser Diagnostics has partnered with laboratory automation technology provider Hamilton Bonaduz to automate the library preparation of its NGS kits and to collaborate in marketing Hamilton's liquid handling technologies.

  • The collaboration aims to combine Devyser's genetic testing solutions with Hamilton's automation technology to speed up processing time and enhance data quality in genetic laboratories. 

  • Devyser Diagnostics is a Sweden-based biotechnology company specializing in developing, manufacturing, and selling DNA test kits for hereditary cancer, cystic fibrosis, cardiovascular diseases, and other genetic conditions. The genetic tests use next-generation sequencing and quantitative PCR (qPCR) techniques to detect genetic mutations and alterations for disease diagnosis, prognosis, and guiding treatment decisions.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.